Cholera toxin inhibits HIV-1 replication in human colorectal epithelial HT-29 cells through adenylate cyclase activation

Antiviral Research

Volumn 88, Issue 2, 2010, Pages 207-216

  Gauthier, Sonia ^a   Tremblay, Michel J ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

AIDS; Cholera toxin; Epithelial cells; HIV; Human

Indexed keywords

ADENYLATE CYCLASE; CHOLERA TOXIN B SUBUNIT; ENTEROTOXIN;

ARTICLE; CANCER CELL; COLON CANCER; COLON MUCOSA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN T CELL LEUKEMIA VIRUS; LIFE CYCLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1; VESICULAR STOMATITIS VIRUS; VIBRIO CHOLERAE;

EID: 77958154041     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.08.015     Document Type: Article

References (65)

1. Banas B., Eberle J., Banas B., Schlondorff D., Luckow B. Modulation of HIV-1 enhancer activity and virus production by cAMP. FEBS Lett. 2001, 509(2):207-212.
2. Barrero-Villar M., Cabrero J.R., Gordon-Alonso M., Barroso-Gonzalez J., Alvarez-Losada S., Munoz-Fernandez M.A., Sanchez-Madrid F., Valenzuela-Fernandez A. Moesin is required for HIV-1-induced CD4-CXCR4 interaction. F-actin redistribution, membrane fusion and viral infection in lymphocytes. J. Cell Sci. 2009, 122(Pt 1):103-113.
3. Bos J.L., de Bruyn K., Enserink J., Kuiperij B., Rangarajan S., Rehmann H., Riedl J., de Rooij J., van Mansfeld F., Zwartkruis F. The role of Rap1 in integrin-mediated cell adhesion. Biochem. Soc. Trans. 2003, 31(Pt 1):83-86.
4. Bounou S., Leclerc J.E., Tremblay M.J. Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo. J. Virol. 2002, 76(3):1004-1014.
5. Broeck D.V., Lagrou A.R., De Wolf M.J. Distinct role of clathrin-mediated endocytosis in the functional uptake of cholera toxin. Acta Biochim. Pol. 2007, 54(4):757-767.
6. Buckley N.E., Su Y., Milstien S., Spiegel S. The role of calcium influx in cellular proliferation induced by interaction of endogenous ganglioside GM1 with the B subunit of cholera toxin. Biochim. Biophys. Acta 1995, 1256(3):275-283.
7. Campbell E.M., Nunez R., Hope T.J. Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity. J. Virol. 2004, 78(11):5745-5755.
8. Cantin R., Fortin J.F., Lamontagne G., Tremblay M. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity. J. Virol. 1997, 71(3):1922-1930.
9. Chang L.J., Urlacher V., Iwakuma T., Cui Y., Zucali J. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system. Gene Ther. 1999, 6(5):715-728.
10. Chowdhury M.I., Koyanagi Y., Horiuchi S., Hazeki O., Ui M., Kitano K., Golde D.W., Takada K., Yamamoto N. cAMP stimulates human immunodeficiency virus (HIV-1) from latently infected cells of monocyte-macrophage lineage: synergism with TNF-alpha. Virology 1993, 194(1):345-349.
11. Cole S.W., Jamieson B.D., Zack J.A. cAMP up-regulates cell surface expression of lymphocyte CXCR4: implications for chemotaxis and HIV-1 infection. J. Immunol. 1999, 162(3):1392-1400.
12. Coovadia H., Kindra G. Breastfeeding to prevent HIV transmission in infants: balancing pros and cons. Curr. Opin. Infect. Dis. 2008, 21(1):11-15.
13. Cristillo A.D., Highbarger H.C., Dewar R.L., Dimitrov D.S., Golding H., Bierer B.E. Up-regulation of HIV coreceptor CXCR4 expression in human T lymphocytes is mediated in part by a cAMP-responsive element. FASEB J. 2002, 16(3):354-364.
14. Cristillo A.D., Xiao X., Campbell-Malone R., Dimitrov D.S., Bierer B.E. Differences between CEM and human peripheral blood T lymphocytes in cAMP-dependent HIV viral fusion and CXCR4 expression. Exp. Mol. Pathol. 2002, 73(1):9-18.
15. Daenke S., Booth S. Molecular mechanisms affecting HTLV type 1-dependent fusion at the cell membrane: implications for inhibiting viral transmission. AIDS Res. Hum. Retroviruses 2000, 16(16):1731-1736.
16. De Haan L., Hirst T.R. Cholera toxin: a paradigm for multi-functional engagement of cellular mechanisms. Mol. Membr. Biol. 2004, 21(2):77-92. (Review).
17. Delezay O., Koch N., Yahi N., Hammache D., Tourres C., Tamalet C., Fantini J. Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29. Aids 1997, 11(11):1311-1318.
18. Eitzen G. Actin remodeling to facilitate membrane fusion. Biochim. Biophys. Acta 2003, 1641(2-3):175-181.
19. Fantini J., Maresca M., Hammache D., Yahi N., Delezay O. Glycosphingolipid (GSL) microdomains as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: activation of signal transduction pathways and perturbations of intestinal absorption and secretion. Glycoconj J. 2000, 17(3-4):173-179.
20. Flemstrom G., Sjoblom M. Epithelial cells and their neighbors II. New perspectives on efferent signaling between brain, neuroendocrine cells, and gut epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 289(3):G377-G380.
21. Fujimoto L.M., Roth R., Heuser J.E., Schmid S.L. Actin assembly plays a variable, but not obligatory role in receptor-mediated endocytosis in mammalian cells. Traffic 2000, 1(2):161-171.
22. Gauthier S., Tremblay M.J. Interleukin-4 inhibits an early phase in the HIV-1 life cycle in the human colorectal cell line HT-29. Clin. Immunol. 2010, 135(1):146-155.
23. Girard M.P., Steele D., Chaignat C.L., Kieny M.P. A review of vaccine research and development: human enteric infections. Vaccine 2006, 24(15):2732-2750.
24. Goichberg P., Kalinkovich A., Borodovsky N., Tesio M., Petit I., Nagler A., Hardan I., Lapidot T. cAMP-induced PKCzeta activation increases functional CXCR4 expression on human CD34+ hematopoietic progenitors. Blood 2006, 107(3):870-879.
25. Hazes B., Read R.J. Accumulating evidence suggests that several AB-toxins subvert the endoplasmic reticulum-associated protein degradation pathway to enter target cells. Biochemistry 1997, 36(37):11051-11054.
26. Hirshman C.A., Zhu D., Pertel T., Panettieri R.A., Emala C.W. Isoproterenol induces actin depolymerization in human airway smooth muscle cells via activation of an Src kinase and GS. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 288(5):L924-L931.
27. Hochbaum D., Tanos T., Ribeiro-Neto F., Altschuler D., Coso O.A. Activation of JNK by Epac is independent of its activity as a Rap guanine nucleotide exchanger. J. Biol. Chem. 2003, 278(36):33738-33746.
28. Howe A.K. Regulation of actin-based cell migration by cAMP/PKA. Biochim. Biophys. Acta 2004, 1692(2-3):159-174.
29. Huang C., Rajfur Z., Borchers C., Schaller M.D., Jacobson K. JNK phosphorylates paxillin and regulates cell migration. Nature 2003, 424(6945):219-223.
30. Iyengar S., Hildreth J.E., Schwartz D.H. Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells. J. Virol. 1998, 72(6):5251-5255.
31. Janoff E.N., Smith P.D. Emerging concepts in gastrointestinal aspects of HIV-1 pathogenesis and management. Gastroenterology 2001, 120(3):607-621.
32. Jimenez-Baranda S., Gomez-Mouton C., Rojas A., Martinez-Prats L., Mira E., Ana Lacalle R., Valencia A., Dimitrov D.S., Viola A., Delgado R., Martinez A.C., Manes S. Filamin-A regulates actin-dependent clustering of HIV receptors. Nat. Cell Biol. 2007, 9(7):838-846.
33. Jordan N.J., Kolios G., Abbot S.E., Sinai M.A., Thompson D.A., Petraki K., Westwick J. Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. J. Clin. Invest. 1999, 104(8):1061-1069.
34. Kagnoff M.F., Roebuck K.A. Human immunodeficiency virus type 1 (HIV-1) infection and expression in intestinal epithelial cells: role of protein kinase A and C pathways in HIV-1 transcription. J. Infect. Dis. 1999, 179(3):S444-S447.
35. Kirkham M., Fujita A., Chadda R., Nixon S.J., Kurzchalia T.V., Sharma D.K., Pagano R.E., Hancock J.F., Mayor S., Parton R.G. Ultrastructural identification of uncoated caveolin-independent early endocytic vehicles. J. Cell Biol. 2005, 168(3):465-476.
36. Kooistra M.R., Dube N., Bos J.L. Rap1: a key regulator in cell-cell junction formation. J. Cell Sci. 2007, 120(Pt 1):17-22.
37. Lavelle E.C., Jarnicki A., McNeela E., Armstrong M.E., Higgins S.C., Leavy O., Mills K.H. Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent. J. Leukoc. Biol. 2004, 75(5):756-763.
38. Lehman D.A., Farquhar C. Biological mechanisms of vertical human immunodeficiency virus (HIV-1) transmission. Rev. Med. Virol. 2007, 17(6):381-403.
39. Lencer W.I., Constable C., Moe S., Jobling M.G., Webb H.M., Ruston S., Madara J.L., Hirst T.R., Holmes R.K. Targeting of cholera toxin and Escherichia coli heat labile toxin in polarized epithelia: role of COOH-terminal KDEL. J. Cell Biol. 1995, 131(4):951-962.
40. Lencer W.I., Hirst T.R., Holmes R.K. Membrane traffic and the cellular uptake of cholera toxin. Biochim. Biophys. Acta 1999, 1450(3):177-190.
41. Lotfi S., Li Z., Sun J., Zuo Y., Lam P.P., Kang Y., Rahimi M., Islam D., Wang P., Gaisano H.Y., Jin T. Role of the exchange protein directly activated by cyclic adenosine 5'-monophosphate (Epac) pathway in regulating proglucagon gene expression in intestinal endocrine L cells. Endocrinology 2006, 147(8):3727-3736.
42. Maillet M., Robert S.J., Cacquevel M., Gastineau M., Vivien D., Bertoglio J., Zugaza J.L., Fischmeister R., Lezoualc'h F. Crosstalk between Rap1 and Rac regulates secretion of sAPPalpha. Nat. Cell Biol. 2003, 5(7):633-639.
43. Massi P., Rubino T., Parenti M., Giagnoni G., Groppetti A., Parolaro D. Cholera toxin antagonizes morphine-induced catalepsy through a cyclic AMP-independent mechanism. Eur. J. Pharmacol. 1993, 243(1):65-71.
44. Massol R.H., Larsen J.E., Fujinaga Y., Lencer W.I., Kirchhausen T. Cholera toxin toxicity does not require functional Arf6- and dynamin-dependent endocytic pathways. Mol. Biol. Cell 2004, 15(8):3631-3641.
45. McClure M.O., Sommerfelt M.A., Marsh M., Weiss R.A. The pH independence of mammalian retrovirus infection. J. Gen. Virol. 1990, 71(Pt 4):767-773.
46. Meng G., Wei X., Wu X., Sellers M.T., Decker J.M., Moldoveanu Z., Orenstein J.M., Graham M.F., Kappes J.C., Mestecky J., Shaw G.M., Smith P.D. Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells. Nat. Med. 2002, 8(2):150-156.
47. Nelson J.A., Wiley C.A., Reynolds-Kohler C., Reese C.E., Margaretten W., Levy J.A. Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet 1988, 1(8580):259-262.
48. Orlandi P.A., Fishman P.H. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J. Cell Biol. 1998, 141(4):905-915.
49. Rabbi M.F., Al-Harthi L., Roebuck K.A. TNFalpha cooperates with the protein kinase A pathway to synergistically increase HIV-1 LTR transcription via downstream TRE-like cAMP response elements. Virology 1997, 237(2):422-429.
50. Rabbi M.F., al-Harthi L., Saifuddin M., Roebuck K.A. The cAMP-dependent protein kinase A and protein kinase C-beta pathways synergistically interact to activate HIV-1 transcription in latently infected cells of monocyte/macrophage lineage. Virology 1998, 245(2):257-269.
51. Rangarajan S., Enserink J.M., Kuiperij H.B., de Rooij J., Price L.S., Schwede F., Bos J.L. Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor. J. Cell Biol. 2003, 160(4):487-493.
52. Rodrigues P., Heard J.M. Modulation of phosphate uptake and amphotropic murine leukemia virus entry by posttranslational modifications of PIT-2. J. Virol. 1999, 73(5):3789-3799.
53. Sack D.A., Sack R.B., Nair G.B., Siddique A.K. Cholera. Lancet 2004, 363(9404):223-233.
54. Sanchez J., Holmgren J. Cholera toxin structure, gene regulation and pathophysiological and immunological aspects. Cell. Mol. Life Sci. 2008, 65(9):1347-1360.
55. Serezani C.H., Ballinger M.N., Aronoff D.M., Peters-Golden M. Cyclic AMP: master regulator of innate immune cell function. Am. J. Respir. Cell Mol. Biol. 2008, 39(2):127-132.
56. Smith P.D., Meng G., Salazar-Gonzalez J.F., Shaw G.M. Macrophage HIV-1 infection and the gastrointestinal tract reservoir. J. Leukoc. Biol. 2003, 74(5):642-649.
57. Steinberg E.B., Greene K.D., Bopp C.A., Cameron D.N., Wells J.G., Mintz E.D. Cholera in the United States, 1995-2000: trends at the end of the twentieth century. J. Infect. Dis. 2001, 184(6):799-802.
58. Superti F., Seganti L., Ruggeri F.M., Tinari A., Donelli G., Orsi N. Entry pathway of vesicular stomatitis virus into different host cells. J. Gen. Virol. 1987, 68(Pt 2):387-399.
59. Uhal B.D., Papp M., Flynn K., Steck M.E. Cholera toxin stimulates type II pneumocyte proliferation by a cyclic AMP-independent mechanism. Biochim. Biophys. Acta 1998, 1405(1-3):99-109.
60. Van de Perre P. Transmission of human immunodeficiency virus type 1 through breast-feeding: how can it be prevented?. J. Infect. Dis. 1999, 179(3):S405-S407.
61. Vanden Broeck D., Horvath C., De Wolf M.J. Vibrio cholerae: cholera toxin. Int. J. Biochem. Cell Biol. 2007, 39(10):1771-1775.
62. Wang W., Jobbagy Z., Bird T.H., Eiden M.V., Anderson W.B. Cell signaling through the protein kinases cAMP-dependent protein kinase, protein kinase Cepsilon, and RAF-1 regulates amphotropic murine leukemia virus envelope protein-induced syncytium formation. J. Biol. Chem. 2005, 280(17):16772-16783.
63. Yoder A., Yu D., Dong L., Iyer S.R., Xu X., Kelly J., Liu J., Wang W., Vorster P.J., Agulto L., Stephany D.A., Cooper J.N., Marsh J.W., Wu Y. HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells. Cell 2008, 134(5):782-792.
64. Zar J. Biostatistical Analysis 1984, Prentice Hall, Eglewoods Cliffs, NJ.
65. Zhang R.G., Scott D.L., Westbrook M.L., Nance S., Spangler B.D., Shipley G.G., Westbrook E.M. The three-dimensional crystal structure of cholera toxin. J. Mol. Biol. 1995, 251(4):563-573.